Clinical Trial Update: Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating BAT1706 (bevacizumab biosimilar) versus comparators in healthy subjects; non-small cell lung cancer is listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BAT1706 (BAT1706)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: NSCLC | Phase 1 | Status: COMPLETED